5 assets in Inherited Sideroblastic Anemia

Therapeutic assets addressing Inherited Sideroblastic Anemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fludarabine Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)
Tacrolimus Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)
Methotrexate Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	CCC (55)
Lapine T-Lymphocyte Immune Globulin Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	CCC (48)